Cargando…

Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan

A questionnaire (Migraine Questionnaire; MQ) was developed to help pharmacists identify consumers with migraine suitable for non-prescription treatment with a triptan. Adults, who knew or thought that they had migraine, participated in three, sequential, community-based studies to validate the MQ. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Diener, Hans-Christoph, Dowson, Andrew, Whicker, Susan, Bacon, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452080/
https://www.ncbi.nlm.nih.gov/pubmed/18953489
http://dx.doi.org/10.1007/s10194-008-0070-6
_version_ 1782244430940471296
author Diener, Hans-Christoph
Dowson, Andrew
Whicker, Susan
Bacon, Teresa
author_facet Diener, Hans-Christoph
Dowson, Andrew
Whicker, Susan
Bacon, Teresa
author_sort Diener, Hans-Christoph
collection PubMed
description A questionnaire (Migraine Questionnaire; MQ) was developed to help pharmacists identify consumers with migraine suitable for non-prescription treatment with a triptan. Adults, who knew or thought that they had migraine, participated in three, sequential, community-based studies to validate the MQ. Overall, 1,353 subjects completed independent assessments with a pharmacist and a clinician (reference standard). The accuracy of the pharmacist assessment of suitability for a triptan was compared with the clinician assessment. Clinicians using their standard practice determined that triptan therapy was suitable in 76.8% of cases compared with 48.8% for pharmacists using the MQ. The lack of concordance between pharmacists and clinicians in the false-positive cases (n = 113 of 660 subjects considered suitable for triptan by the pharmacists) usually related to headache diagnosis (57.5%), not safety aspects. The MQ is an effective tool for pharmacists to guide appropriate recommendation of a non-prescription triptan for migraine. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10194-008-0070-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3452080
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-34520802012-11-29 Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan Diener, Hans-Christoph Dowson, Andrew Whicker, Susan Bacon, Teresa J Headache Pain Original A questionnaire (Migraine Questionnaire; MQ) was developed to help pharmacists identify consumers with migraine suitable for non-prescription treatment with a triptan. Adults, who knew or thought that they had migraine, participated in three, sequential, community-based studies to validate the MQ. Overall, 1,353 subjects completed independent assessments with a pharmacist and a clinician (reference standard). The accuracy of the pharmacist assessment of suitability for a triptan was compared with the clinician assessment. Clinicians using their standard practice determined that triptan therapy was suitable in 76.8% of cases compared with 48.8% for pharmacists using the MQ. The lack of concordance between pharmacists and clinicians in the false-positive cases (n = 113 of 660 subjects considered suitable for triptan by the pharmacists) usually related to headache diagnosis (57.5%), not safety aspects. The MQ is an effective tool for pharmacists to guide appropriate recommendation of a non-prescription triptan for migraine. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10194-008-0070-6) contains supplementary material, which is available to authorized users. Springer Milan 2008-10-25 /pmc/articles/PMC3452080/ /pubmed/18953489 http://dx.doi.org/10.1007/s10194-008-0070-6 Text en © The Author(s) 2008 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original
Diener, Hans-Christoph
Dowson, Andrew
Whicker, Susan
Bacon, Teresa
Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
title Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
title_full Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
title_fullStr Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
title_full_unstemmed Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
title_short Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
title_sort development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452080/
https://www.ncbi.nlm.nih.gov/pubmed/18953489
http://dx.doi.org/10.1007/s10194-008-0070-6
work_keys_str_mv AT dienerhanschristoph developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan
AT dowsonandrew developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan
AT whickersusan developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan
AT baconteresa developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan